An Investigation of the Factors Related to Attitudes Towards Hospice and Palliative Care Among the Bunun Tribe in Taiwan

May 31, 2025 updated by: Kwo-Chen Lee, China Medical University Hospital

An Investigation of the Factors Related to Attitudes Towards Hospice and Palliative Care Among the Bunun Tribe in Taiwan: A Case Study of the Lona Village in Nantou

This study aims to investigate the factors related to attitudes towards hospice and palliative care among the Bunun tribe in Taiwan, with a specific focus on the influence of faith maturity and resilience. A cross-sectional study will be conducted in Lona Village, Nantou County, enrolling 82 Bunun participants aged 20 and above, who have resided in the village for at least 20 years. Participants must possess basic literacy skills and will complete structured questionnaires assessing faith maturity, resilience, and attitudes towards hospice and palliative care. Pearson correlation tests will be used for data analysis, with significance set at p < 0.05. The expected outcome is to provide empirical data on the relationship between faith maturity, resilience, and attitudes towards hospice care among the Bunun, contributing to healthcare policy tailored to Indigenous communities.

Study Overview

Status

Completed

Conditions

Detailed Description

The detailed design of this study emphasizes the cultural and spiritual dimensions that influence the Bunun tribe is attitudes toward hospice and palliative care. The Bunun tribe's cultural perspectives on death, illness, and caregiving differ from other ethnic groups in Taiwan. Faith plays a crucial role in the daily lives of the Bunun, while resilience reflects their capacity to cope with adversity, both of which may be key determinants of their attitudes toward hospice care.

Validated research instruments, such as the Faith Maturity Scale and Resilience Scale, are used to assess the participant is faith and psychological conditions. Additionally, the Attitudes Toward Hospice and Palliative Care Scale will help researchers gauge the level of acceptance and potential concerns regarding hospice care.

The cross-sectional design allows for the collection of sufficient data for an initial analysis to identify the relationship between faith maturity, resilience, and attitudes toward hospice care. Based on these findings, the research team will be able to provide specific recommendations to improve awareness and acceptance of hospice care among the Bunun and other Indigenous communities in Taiwan, thus contributing to more culturally appropriate healthcare service designs and policies.

Study Type

Observational

Enrollment (Actual)

82

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Taiwan
      • Nantou City, Taiwan, 556
        • Luona Village, Xinyi Township, Nantou City, Taiwan 556

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

(1) being twenty years of age or older; (2) residing in Lona Village, Xinyi Township, Nantou County for at least twenty years; (3) being literate with at least an elementary level of reading ability to complete structured questionnaires.

Description

Inclusion Criteria:

Aged 20 years or older Resided in Lona Village, Xinyi Township, Nantou County for at least 20 years Literate with at least an elementary level of reading ability to complete structured questionnaires

Exclusion Criteria:

Individuals with hearing impairments or speech disorders Individuals diagnosed with emotional disorders by a physician

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Explore the current status and related factors of faith maturity, resilience, and attitudes towards hospice and palliative care among the Bunun tribe in Taiwan.
Time Frame: The plan is to collect structured questionnaire responses from 82 Bunun Indigenous people within three months.

Structured questionnaires will be administered to 82 Bunun Indigenous adults to assess:

  1. Faith Maturity (FMS, score range: 12-84; higher = greater faith maturity)
  2. Resilience (RS-14, score range: 14-98; higher = greater resilience)
  3. Palliative Care Attitudes (score range: 20-100; higher = more favorable attitudes)
The plan is to collect structured questionnaire responses from 82 Bunun Indigenous people within three months.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

China Medical University Hospital

Investigators

  • Study Director: KwoChen Lee, ph.D, 011+886+4+22053366#7102

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 11, 2024

Primary Completion (Actual)

October 24, 2024

Study Completion (Actual)

January 30, 2025

Study Registration Dates

First Submitted

April 28, 2025

First Submitted That Met QC Criteria

May 31, 2025

First Posted (Actual)

June 10, 2025

Study Record Updates

Last Update Posted (Actual)

June 10, 2025

Last Update Submitted That Met QC Criteria

May 31, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • CMUH113-REC3-127

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Resilience

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Latvia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe